Merck Canada has announced a new initiative aimed at supporting Indigenous students in their pursuit of higher education. The pharmaceutical giant has launched the “Merck Canada Indigenous Student Scholarship” in collaboration with Universities Canada/Universités Canada.
Empowering Indigenous Learners
The scholarship program seeks to provide financial assistance and encouragement to Indigenous individuals who wish to pursue or are currently enrolled in undergraduate studies. Marie-Claude Lapointe, Director of Human Resources at Merck Canada, acknowledged the hurdles that Indigenous students often encounter, such as financial constraints, lack of resources, and systemic barriers. The company hopes this scholarship will empower Indigenous, Inuit, and Métis students to achieve their academic ambitions.
Program Details
The Merck Canada Indigenous Student Scholarship offers a bursary of $5,000 CAD for Indigenous students pursuing an undergraduate degree in any field of study.
Up to eight scholarships will be available for the 2024-2025 academic year
Up to eight scholarships will be available for the 2024-2025 academic year. Indigenous, Inuit, and Métis students entering or returning to full-time studies in a first Bachelor’s (undergraduate) program are eligible to apply through the scholarship application portal.
The application window is open from March 5 to April 5, 2024, and successful applicants will receive their scholarships for the 2024 fall university term. Indigenous, Inuit, and Métis students entering or returning to full-time studies in a first Bachelor (undergraduate program) in the 2024-2025 academic year are invited to apply through the scholarship application portal.
About Merck
Merck, known as MSD outside of the United States and Canada, is a global biopharmaceutical company committed to using leading-edge science to save and improve lives worldwide. With over 130 years of experience, Merck has brought hope to humanity through the development of essential medicines and vaccines. The company aspires to be the premier research-intensive biopharmaceutical company globally and is at the forefront of innovative health solutions for the prevention and treatment of diseases in humans and animals.
In Canada, Merck markets a diverse range of vaccines, pharmaceutical products, and animal health products. The company is one of the top investors in research and development in Canada, with investments totaling more than $90 million in 2022 and over $1.6 billion since 2000. Based in Kirkland, Québec, Merck employs approximately 635 people across the country. For more information about Merck’s operations in Canada, visit www.merck.ca and connect with them on LinkedIn @MerckCanada.
